Drreddys Laboratories | RDY - Assets


Drreddys Laboratories reported INR6.26B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
ANI Pharmaceuticals USD 1.44B 32.22M Dec/2025
Aurora Cannabis CAD 756.86M 80.98M Sep/2025
Bayer EUR 104.54B 331M Dec/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Cipla INR 401.64B 27.77B Sep/2025
Corcept Therapeutics USD 836.65M 13.04M Dec/2025
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 19.73B 1.85B Dec/2024
Novartis USD 107.29B 2.89B Sep/2025
Pacira USD 1.26B 32.66M Dec/2025
Phibro Animal Health USD 1.41B 20.03M Dec/2025
Prestige Brands USD 3.49B 52.46M Dec/2025
Richter Gedeon HUF 1.68T 39.69B Dec/2025
Sun Pharmaceuticals INR 1.04T 116.06B Sep/2025
Supernus Pharmaceuticals USD 1.45B 32.89M Dec/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025